This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsResearch on Leishmaniasis Studies · Synthesis and Characterization of Heterocyclic Compounds · Blood Coagulation and Thrombosis Mechanisms
After this article [1] was published, concerns were raised regarding results presented in Figs 2 and 5.
Specifically:
Corresponding author RB disagreed with the above concerns. They provided some of the raw FACS data files, details of the gating strategy underlying Fig 2, and replicate data from the time of the original experiments for Fig 5. PLOS does not consider the above concerns to be resolved in the absence of the full original underlying data for the figures of concern. Additionally, editorial assessment of the provided FACS data raised further concerns for the reliability and validity of the published results.
In light of the above concerns, the PLOS Neglected Tropical Diseases Editors retract this article.
SK, SKJ, JJJ, SG, and RB did not agree with the retraction and stand by the article’s findings. DD did not agree with the retraction. JD responded but expressed neither agreement nor disagreement with the editorial decision. SD, SAN, and SM either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.